Equities

Emami Ltd

EMAMILTD:NSI

Emami Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (INR)625.50
  • Today's Change13.65 / 2.23%
  • Shares traded10.24m
  • 1 Year change+59.69%
  • Beta1.0012
Data delayed at least 15 minutes, as of May 31 2024 11:24 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Emami Limited is an India-based company, which is focused on personal and healthcare businesses in India. The Company is engaged in the business of manufacturing health, beauty and personal care products. The Company’s brands, including BoroPlus, Navratna, Zandu, Fair and Handsome, Kesh King, Mentho plus balm, Dermicool, 7 Oils in One, HE, Diamond Shine, Emami Golden Beauty, Emami Naturally Fair, Emami Emasol and Creme21. It has a portfolio of over 300 + products based on ayurvedic formulations. Its operations comprise more than 60 countries, including SAARC, MENAP, SEA, Africa, Eastern Europe and the CIS countries. It provides Ayurvedic Antiseptic Cream, Prickly Heat Powder, Doodh Kesar Body Lotion, Vasocare Herbal Petroleum Jelly, Aloe Vera Gel, Hygiene Range, Cool Oil, Extra Thanda, Gold Ayurvedic Oil and others. It has manufacturing units in India and abroad to develop products suited to meet the diverse needs and preferences of consumers in different markets.

  • Revenue in INR (TTM)35.78bn
  • Net income in INR7.24bn
  • Incorporated1983
  • Employees3.24k
  • Location
    Emami LtdEmami Tower, 687 Anandapur,, EM BypassKOLKATA 700107IndiaIND
  • Phone+91 3 366136264
  • Fax+91 3 366136600
  • Websitehttp://www.emamiltd.in/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
EMAMILTD:NSI since
announced
Transaction
value
Brillare Science Pvt LtdDeal completed27 Mar 202427 Mar 2024Deal completed43.79%--
Data delayed at least 15 minutes, as of May 31 2024 11:24 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
TTK Prestige Ltd26.78bn2.28bn94.69bn1.42k41.134.5432.683.5416.4916.49193.27149.531.002.758.54--8.4510.9810.4214.0141.1840.098.419.742.7417.850.079228.65-3.574.91-10.113.503.3914.87
Jyothy Labs Ltd27.57bn3.69bn147.07bn2.60k39.778.1335.085.3310.0710.0775.1449.241.244.8016.26--16.5511.1620.6814.5949.0844.0413.4010.141.7890.880.027251.5010.908.7454.1112.49-1.473.13
Gillette India Limited26.07bn3.87bn232.62bn571.0060.03--49.438.92118.91118.91800.11--------45,660,070.00--20.15--31.7553.7452.2914.8613.99--56.36--75.439.798.1222.939.20-0.581629.88
Emami Ltd35.78bn7.24bn274.64bn3.24k37.7911.2330.187.6816.5516.5581.8055.721.123.567.87--22.6720.4329.6427.9167.5765.7920.2418.751.4455.740.0368--5.065.8513.1319.00-21.8514.87
Procter & Gamble Hygiene & Health Care41.26bn7.45bn518.45bn432.0069.57--64.5112.56229.57229.571,271.24--------95,520,370.00--32.29--57.6861.3849.0218.0615.90--33.77--68.620.43539.8017.7812.603.1235.84
Colgate-Palmolive (India) Ltd56.80bn13.24bn722.76bn2.32k54.6138.5648.3412.7248.6648.66208.8268.911.875.4534.98--43.5437.3570.4963.1569.6762.2323.3020.891.30346.550.036999.038.694.9526.4111.28-11.4515.85
Dabur India Ltd124.04bn18.43bn966.09bn5.32k52.519.7943.707.7910.3810.3869.8755.680.86213.2514.20--12.5914.5017.8220.2548.0347.9214.6015.820.949716.050.11743.887.587.777.945.0219.200.00
Godrej Consumer Products Limited140.96bn-5.61bn1.30tn2.51k--10.31--9.22-5.48-5.48137.83123.170.78324.5010.14---3.117.68-4.1310.3955.1650.40-3.9810.030.76756.690.2037--5.866.45-132.93--8.149.95
Data as of May 31 2024. Currency figures normalised to Emami Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

20.63%Per cent of shares held by top holders
HolderShares% Held
DSP Asset Managers Pvt. Ltd.as of 30 Apr 202418.65m4.25%
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 30 Apr 202413.19m3.01%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 30 Apr 20249.67m2.20%
Kotak Mahindra Asset Management Co. Ltd.as of 30 Apr 20249.38m2.14%
The Vanguard Group, Inc.as of 09 May 20247.80m1.78%
Franklin Templeton Asset Management (India) Pvt Ltd.as of 30 Apr 20247.61m1.73%
HDFC Life Insurance Co. Ltd. (Investment Portfolio)as of 30 Apr 20246.83m1.56%
UTI Asset Management Co. Ltd. (Investment Management)as of 30 Apr 20246.11m1.39%
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 30 Apr 20245.75m1.31%
Invesco Advisers, Inc.as of 31 Mar 20245.58m1.27%
More ▼
Data from 31 Mar 2024 - 23 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.